14
GASTROINTESTINAL DISORDERS
Clinical Effectiveness*
* Patients with dyspepsia (suspected new or recurring acute or chronic gastritis) or heartburn
Gastricumeel® is as effective as PPIs2
Gastricumeel® was as effective as PPIs in reduction of all 8 recorded symptoms2
Gastricumeel® improved symptoms in almost 90% of patients after 6 weeks, comparable to PPIs2
Reduction average symptom scores on a 3 point scale
PPIs (n=183)
Gastricumeel (n=434)
-1
-2
0
A cid
eru ctatio
n
A b
d om
inal p ain
A b
d om
inal fulln ess
H un
g er p
ain
Pyrosis
D ysp
hagia
N ausea
A ctual degree of serverity
of the disease
V om
itin g
mild 1
moderate 2
severe 3
At baseline the symptoms and disease severity were assessed in scores from 1, 2 to 3 (mild, moderate or severe)
Reduction in average symptom scores at final examination compared to baseline with 95% CIs, adjusted for the propensity scores and baseline values
References 2) Van Haselen, R., Cesnulevicius, K. Treatment of Dyspepsia, Heartburn, and Related Symptoms with Gastricumeel Compared to Proton Pump Inhibitors: A Prospective
Reference-Controlled Observational Study. Complement Med Res (2020): DOI: 10.1159/000511285. Online link: https://www.karger.com/Article/Fulltext/511285
